APA (7th ed.) Citation

Yan, M., Liu, X., Zhang, Y., Ding, H., Zhong, M., & Ma, C. Rationale and design of a prospective study evaluating population pharmacokinetics and pharmacodynamics of rivaroxaban in Chinese patients with non-valvular atrial fibrillation. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Yan, Ming-Ming, Xiao-Qin Liu, Yu-Fei Zhang, Hong-Yan Ding, Ming-Kang Zhong, and Chun-Lai Ma. Rationale and Design of a Prospective Study Evaluating Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Chinese Patients with Non-valvular Atrial Fibrillation. BMJ Publishing Group.

MLA (9th ed.) Citation

Yan, Ming-Ming, et al. Rationale and Design of a Prospective Study Evaluating Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Chinese Patients with Non-valvular Atrial Fibrillation. BMJ Publishing Group.